-
Alternative_name
(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine
-
Description
Varlitinib is a potent inhibitor of the epidermal growth factor receptor (EGFR) family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone.
-
CAS Number
845272-21-1
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₂₂H₁₉ClN₆O₂S
-
Molecular Weight
466.94
-
Cell Permeable
Yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO
-
Handling
Protect from air and light
-
Tag Line
A potent EGFR family inhibitor
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
36 months
-
PubChem CID
42642648
-
-
SMILES
CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl
-
InChi
InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1
-
InChi Key
UWXSAYUXVSFDBQ-CYBMUJFWSA-N
-
-
MSDS Available
Yes
